EcoDrugPlus

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSCHYG00000015871
Gene Symbol: DPYD
1 Cross references
228 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSCHYG00000005237
Gene Symbol: DDR2
1 Cross references
264 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSCHYG00000005319
Gene Symbol: DRD1
1 Cross references
262 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSCHYG00000001660
Gene Symbol: DRD2
1 Cross references
222 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSCHYG00000023920
Gene Symbol: DRD3
1 Cross references
209 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSCHYG00000020974
Gene Symbol: DRD5
1 Cross references
164 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSCHYG00000014418
Gene Symbol: ENPP2
1 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSCHYG00000027170
Gene Symbol: EGLN2
1 Cross references
192 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSCHYG00000006118
Gene Symbol: EGLN3
1 Cross references
208 Possible Orthologues:

Elastase, Neutrophil Expressed

Ensembl ID : ENSCHYG00000007890
Gene Symbol: ELANE
1 Cross references
91 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSCHYG00000017145
Gene Symbol: EPAS1
1 Cross references
225 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSCHYG00000004904
Gene Symbol: ECE1
1 Cross references
230 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).